UCSF

ZINC03831405

Substance Information

In ZINC since Heavy atoms Benign functionality
September 30th, 2005 24 Yes

Other Names:

"Quinidine, 98%"

(+)-Quinidine; (3'.alpha., 9S)-6'-Methoxycinchonan-9-ol; (8R,9S)-Quinidine; (9S)-6'-methoxycinchonan-9-ol; (S)-[(4S,5R,7R)-5-ethenyl-1-azabicyclo[2.2.2]octan-7-yl]-(6-methoxyquinolin-4-yl)methanol; 6-Methoxy-alpha-(5-vinyl-2-quinuclidinyl)-4-quinolinemeth

(+)-Quinidine; 56-54-2; C06527; Quinidine

(1S)-(6-Methoxyquinolin-4-yl)((2R,4S,5R)-5-vinylquinuclidin-2-yl)methanol

(5-ethenyl-1-azabicyclo[2.2.2]octan-2-yl)-(6-methoxyquinolin-4-yl)methanol; sulfuric acid

(9S)-6'-Methoxycinchonan-9-ol

(9S)-6'-Methoxycinchonan-9-ol sulfate

1400-48-2; D08459; Natisedine (TN); Quinidine 5-ethyl 5-phenyl barbiturate; Quinidine phenylethylbarbiturate

6'-Methoxycinchonan-9-ol monohydroiodide (8-alpha,9R)-, mixt. with triiodobismuthine; Biioquinol; Bijochinol; Cinchonan-9-ol, 6'-methoxy-, monohydroiodide, (8-alpha,9R)-, mixt. with triiodobismuthine; LS-53756; Quinine bismuth iodide; Quinobine

6-Methoxy-cinchonan-9-ol, (8-alpha,9R)-, compd. with 2-carboxyphenyl-2-hydroxybenzoate (1:2); LS-141256; Quinine, compd. with salicylic acid salicylicate; Quinisal; Quinisan

6151-40-2; CPD000857275; Quinidine hydrochloride monohydrate; SAM002264644

6151-40-2; Prestwick_589; Quinidine hydrochloride monohydrate

6591-63-5; D02272; Quinidex (TN); Quinidine sulfate (USP); Quinidine sulfate hydrate (JP16)

7

Apo-Quinidine

Biquin Durules

BRD-A17470778-001-02-9

BRD-A25834361-001-01-1

BRD-K70799801-311-02-7

C20H24N2O2.C6H12O7; Cinchonan-9-ol, 6'-methoxy-, (9S)-, mono-D-gluconate (salt); D-Gluconic acid, compd. with (9S)-6'-methoxycinchonan-9-ol (1:1); DURAQUIN; EINECS 230-333-9; Gluconic acid, compd. with quinidine (1:1), D-; LS-71453; QUINACT; QUINAGLUTE; Q

Cardioquin

CHEBI:8720; CHEBI:26495

Chinidin

Cin-Quin

Coccinine

Conchinin

Conchinine

Conquinine

CPD000857275; Quinidine; Quinidine hydrochloride monohydrate; SAM002264644

DNC006402

Duraquin

FDA

GNF-PF-5459

JAN

Kinidin

LS-190657

LS-4562

METHOXYQUINOLINYLVINYLQUINUCLIDINYLMETHANO

MFCD00067566

MFCD00078498

MFCD00135581

MFCD00267276

MFCD01570898

MFCD02667659

MFCD03939586

MFCD03940719

MFCD07808735

MFCD09867795

MI

NA

NF); Quinidine Gluconate (FDA

NF); Quinidine Sulfate (JAN

Novoquinidin

OR-3804

Pitayin

Pitayine

Quin-Release

Quinact

Quinaglute

Quinaglute Dura-Tabs

Quinalan

Quinate

Quinatime

Quindine

Quinicardine

Quinidex

Quinidex Extentabs

Quinidine (BAN

Quinidine ,Quinine bisulfate

quinidine D-gluconate

Quinidine gluconate

Quinidine Gluconate (FDA

Quinidine hydrochloride monohydrate

Quinidine Sulfate

Quinidine sulfate salt dihydrate

Quinidine, 98%, anhydrous

quinidinehydrochloridemonohydrate

Quinine

Quinine hydrochloride

QUININE SULFATE

Quinine, hydrobromide, hydrate; 4-Quinolinemethanol, 6-methoxy-.alpha.-5-vinyl-2-quinuclidinyl hydrobromide

Quinora

USP)

USP); Quinidine (BAN

USP); Quinidine Sulfate (FDA

Download: MOL2 SDF SMILES Flexibase

Annotations

Vendors

Physical Representations

Type pH range xlogP Des A‑Pol Apolar desolvation (kcal/mol) Des Pol Polar desolvation (kcal/mol) H Don H-bond donors H Acc H-bond acceptors Chg Net charge tPSA (Ų) MWT Molecular weight (g/mol) RB Rotatable bonds DL
Ref Reference (pH 7) 3.06 7.47 -38.76 2 4 1 47 325.432 4
Lo Low (pH 4.5-6) 3.06 7.91 -89.66 3 4 2 48 326.44 4

Vendor Notes

Note Type Comments Provided By
Molecular_Solubility 5.444 Bitter DB
MP 168-172° Oakwood Chemical
Mp [°C] 170 - 175 Acros Organics
MP 171-173° Matrix Scientific
MP 172 TCI
ALOGPS_SOLUBILITY 3.34e-01 g/l DrugBank-approved
Purity 95% Fluorochem
Purity 95+% Matrix Scientific
Therapy antiarrhythmic, antimalarial SMDC Iconix
PUBCHEM_PATENT_ID EP0000302A1; EP0000727A1; EP0007116A1; EP0012722A1; EP0013560A1; EP0013561A1; EP0014514A2; EP0014929A1; EP0017908A1; EP0019788A2; EP0021214A1; EP0025864A1; EP0025912A1; EP0026317A1; EP0032286A2; EP0032889A1; EP0033341A1; EP0035360A2; EP0035856A2; EP003858 IBM Patent Data
H phrase H301: Toxic if swallowed Acros Organics
H phrase H301: Toxic if swallowed; H315: Causes skin irritation; H319: Causes serious eye irritation; H335: May cause respiratory irritation Acros Organics
Warnings IRRITANT Matrix Scientific
PUBCHEM_SUBSTANCE_COMMENT NCC_SAMPLE_SUPPLIER : LightBiologicals; NCC_SUPPLIER_STRUCTURE_ID : Q-8596 NIH Clinical Collection via PubChem
P phrase P301+ P312: IF SWALLOWED: Call a POISON CENTER or doctor/physician if you feel unwell Acros Organics
P phrase P301+ P312: IF SWALLOWED: Call a POISON CENTER or doctor/physician if you feel unwell; P280: Wear protective gloves/protective clothing/eye protection/face protection; P305 + P351 + P338: IF IN EYES: Rinse cautiously with water for several minutes. Remove Acros Organics
R phrase R22: Harmful if swallowed. Acros Organics
R phrase R22: Harmful if swallowed.; R36/37/38: Irritating to eyes, respiratory system and skin. Acros Organics
PUBCHEM_SUBSTANCE_COMMENT SAMPLE_SUPPLIER: LightBiologicals; SUPPLIER_STRUCTURE_ID: Q-8596 NIH Clinical Collection via PubChem
Hazard XN: Harmful Acros Organics

Activity (Go SEA)

Clustered Target Annotations
Code Description Organism Class Affinity (nM) LE (kcal/mol/atom) Type
KCNA5-1-E Voltage-gated Potassium Channel Subunit Kv1.5 (cluster #1 Of 3), Eukaryotic Eukaryotes 7300 0.30 Binding ≤ 10μM
KCND2-1-E Potassium Voltage-gated Channel Subfamily D Member 2 (cluster #1 Of 1), Eukaryotic Eukaryotes 2200 0.33 Binding ≤ 10μM
KCNH2-5-E HERG (cluster #5 Of 5), Eukaryotic Eukaryotes 6490 0.30 Binding ≤ 10μM
MDR1-2-E P-glycoprotein 1 (cluster #2 Of 3), Eukaryotic Eukaryotes 5000 0.31 Binding ≤ 10μM
SCN1A-1-E Sodium Channel Protein Type I Alpha Subunit (cluster #1 Of 2), Eukaryotic Eukaryotes 3200 0.32 Binding ≤ 10μM
SCN2A-2-E Sodium Channel Protein Type II Alpha Subunit (cluster #2 Of 2), Eukaryotic Eukaryotes 3200 0.32 Binding ≤ 10μM
SCN3A-1-E Sodium Channel Protein Type III Alpha Subunit (cluster #1 Of 2), Eukaryotic Eukaryotes 3200 0.32 Binding ≤ 10μM
SCN5A-1-E Sodium Channel Protein Type V Alpha Subunit (cluster #1 Of 1), Eukaryotic Eukaryotes 6900 0.30 Binding ≤ 10μM
SCN8A-1-E Sodium Channel Protein Type VIII Alpha Subunit (cluster #1 Of 2), Eukaryotic Eukaryotes 3200 0.32 Binding ≤ 10μM
MDR1-2-E P-glycoprotein 1 (cluster #2 Of 2), Eukaryotic Eukaryotes 5600 0.31 Functional ≤ 10μM
CP2D6-1-E Cytochrome P450 2D6 (cluster #1 Of 3), Eukaryotic Eukaryotes 10 0.47 ADME/T ≤ 10μM
CP2DQ-1-E Cytochrome P450 2D2 (cluster #1 Of 1), Eukaryotic Eukaryotes 2800 0.32 ADME/T ≤ 10μM
Z50425-3-O Plasmodium Falciparum (cluster #3 Of 22), Other Other 4 0.49 Functional ≤ 10μM
Z50426-6-O Plasmodium Falciparum (isolate K1 / Thailand) (cluster #6 Of 9), Other Other 51 0.43 Functional ≤ 10μM
Z81138-1-O ScN2a (Scrapie-infected Neuroblastoma Cells) (cluster #1 Of 3), Other Other 5000 0.31 Functional ≤ 10μM
ChEMBL Target Annotations
Uniprot Swissprot Description Affinity (nM) LE (kcal/mol/atom) Type
KCNH2_HUMAN Q12809 HERG, Human 323.593657 0.38 Binding ≤ 1μM
KCNH2_HUMAN Q12809 HERG, Human 323.593657 0.38 Binding ≤ 10μM
MDR1_HUMAN P08183 P-glycoprotein 1, Human 2600 0.33 Binding ≤ 10μM
KCND2_RAT Q63881 Potassium Voltage-gated Channel Subfamily D Member 2, Rat 2200 0.33 Binding ≤ 10μM
SCN1A_HUMAN P35498 Sodium Channel Protein Type I Alpha Subunit, Human 3200 0.32 Binding ≤ 10μM
SCN2A_HUMAN Q99250 Sodium Channel Protein Type II Alpha Subunit, Human 3200 0.32 Binding ≤ 10μM
SCN3A_HUMAN Q9NY46 Sodium Channel Protein Type III Alpha Subunit, Human 3200 0.32 Binding ≤ 10μM
SCN5A_HUMAN Q14524 Sodium Channel Protein Type V Alpha Subunit, Human 6900 0.30 Binding ≤ 10μM
SCN8A_HUMAN Q9UQD0 Sodium Channel Protein Type VIII Alpha Subunit, Human 3200 0.32 Binding ≤ 10μM
KCNA5_HUMAN P22460 Voltage-gated Potassium Channel Subunit Kv1.5, Human 7300 0.30 Binding ≤ 10μM
MDR1_HUMAN P08183 P-glycoprotein 1, Human 2200 0.33 Functional ≤ 10μM
MDR1_MOUSE P06795 P-glycoprotein 1, Mouse 10000 0.29 Functional ≤ 10μM
Z50425 Z50425 Plasmodium Falciparum 25.1188643 0.44 Functional ≤ 10μM
Z50426 Z50426 Plasmodium Falciparum (isolate K1 / Thailand) 51 0.43 Functional ≤ 10μM
Z81138 Z81138 ScN2a (Scrapie-infected Neuroblastoma Cells) 5000 0.31 Functional ≤ 10μM
CP2DQ_RAT P10634 Cytochrome P450 2D2, Rat 2800 0.32 ADME/T ≤ 10μM
CP2D6_HUMAN P10635 Cytochrome P450 2D6, Human 20 0.45 ADME/T ≤ 10μM

Reactome Annotations from Targets (via Uniprot)

Description Species
Abacavir transmembrane transport
ABC-family proteins mediated transport
CYP2E1 reactions
Fatty acids
Interaction between L1 and Ankyrins
Miscellaneous substrates
Voltage gated Potassium channels
Xenobiotics

Analogs ( Draw Identity 99% 90% 80% 70% )

No pre-computed analogs available. Try a structural similarity search.